Frank Rimerman Advisors’s Pfizer PFE Stock Holding History

Frank Rimerman Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.91M	Buy	174,884 +10,872	+7%	+$289K	0.32%	51
2025 Q4	$4.08M	Sell	164,012 -32,958	-17%	-$831K	0.26%	58
2025 Q3	$5.02M	Buy	196,970 +42,634	+28%	+$1.05M	0.32%	47
2025 Q2	$3.74M	Buy	154,336 +13,743	+10%	+$321K	0.25%	61
2025 Q1	$3.56M	Buy	140,593 +118,471	+536%	+$3.1M	0.28%	58
2024 Q4	$587K	Sell	22,122 -75,752	-77%	-$2.05M	0.04%	272
2024 Q3	$2.83M	Sell	97,874 -4,013	-4%	-$117K	0.2%	82
2024 Q2	$2.85M	Buy	101,887 +101,573	+32,348%	+$2.8M	0.2%	86
2024 Q1	$8.71K	Hold	314	–	–	﹤0.01%	178
2023 Q4	$9.04K	Buy	+314	New	+$9.49K	﹤0.01%	173

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Frank Rimerman Advisors's PFE Position: Q1 2026 in Review

Frank Rimerman Advisors increased its Pfizer (PFE) stake by 6.6% in Q1 2026, buying an estimated $289K and bringing the position to 174,884 shares worth $4.91M. The position accounts for 0.32% of the portfolio, ranked #51.

Frank Rimerman Advisors first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.02M in Q3 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Frank Rimerman Advisors held 174,884 shares of Pfizer worth $4.91M as of Q1 2026.
Frank Rimerman Advisors bought 10,872 Pfizer shares in Q1 2026, an estimated $289K.
Pfizer made up 0.32% of Frank Rimerman Advisors's portfolio in Q1 2026, its #51 holding.
Frank Rimerman Advisors first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
Frank Rimerman Advisors's Pfizer position peaked at $5.02M in Q3 2025.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.